Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002026739 | SCV002312294 | uncertain significance | PRPH2-related disorder | 2021-02-15 | criteria provided, single submitter | clinical testing | This variant is present in population databases (rs755449912, ExAC 0.001%). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt PRPH2 protein function. This variant has not been reported in the literature in individuals with PRPH2-related conditions. This sequence change replaces arginine with cysteine at codon 183 of the PRPH2 protein (p.Arg183Cys). The arginine residue is highly conserved and there is a large physicochemical difference between arginine and cysteine. |